NNLX

 
Common Stock Dark or Defunct
OTC Pink No Information
Contact Info
  • 843 North Main Street
  • Hubbard, OH 44425

Business Description


Update Company Profile
 
Financial Reporting/Disclosure
Reporting Status Dark: Alternative Reporting Standard
Deregistered a/o Sep 08, 2003
Audited Financials Not Available
CIK 0001030065
Fiscal Year End 12/31
OTC Marketplace OTC Pink No Information
Profile Data
SIC - Industry Classification 8731 - Commercial physical research
Business Status Development Stage Company a/o Jul 31, 2012
Incorporated In: DE, USA
Year of Inc. 1989
Employees 11 a/o Jun 01, 2012
Company Officers/Contacts
Bret T. Barnhizer CEO, President
Daniel Barnhizer Esq.
Carol Surena Corporate Secretary
Joshua Barnhizer Corporate Counsel
Company Directors
Bret T. Barnhizer Chairman
Daniel Barnhizer
John Chatterton
Jeff Long
Company Notes
  • Formerly=Infectech, Inc. until 5-05
  • Note=6-00 company is in the development stage, researching & developing diagnostic tests for infectious human diseases
Service Providers
Accounting/Auditing Firm
Not Available
Legal Counsel
Arnold & Porter LLP
399 Park Avenue
New York, NY, 10022
United States

Investor Relations Firm
Not Available
NNLX Security Details
Share Structure
Market Value1 $11,961,051 a/o Jul 28, 2014
Shares Outstanding 119,610,510 a/o Jul 31, 2012
Float 97,017,507 a/o Jul 31, 2012
Authorized Shares 200,000,000 a/o Dec 31, 2008
Par Value 0.02
Shareholders
Shareholders of Record 3,100 a/o Dec 31, 2011
Short Selling Data
Short Interest 24,864 (332.42%)
Jul 15, 2014
Significant Failures to Deliver No
Transfer Agent(s)
Pacific Stock Transfer Co.

1Market Value calculated only for respective security